DirectMeds GLP-1 (often associated with DirectMeds.com) offers telehealth-based access to compounded, non-FDA-approved semaglutide and tirzepatide for weight loss, touting improved insulin regulation and significant weight reduction. However, the FDA issued a warning letter in September 2025 regarding false, misleading claims and unapproved, misbra...   Read more